| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2138420 | Leukemia Research | 2009 | 7 Pages |
Abstract
Additional studies are needed to determine whether the rare discrepancies are a reflection of the cooperative nature of WT1 overexpression or a consequence of the uneven distribution in the leukemic population. WT1 is a powerful MRD tool even in cases with currently available molecular targets.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Adriana Lasa, Maite Carricondo, Camino Estivill, Elena Bussaglia, Ignasi Gich, Salut Brunet, Anna Aventin, Jorge Sierra, Josep F. Nomdedéu,